Skip to main content
. 2020 Feb 15;20:57. doi: 10.1186/s12883-020-01633-3

Fig. 2.

Fig. 2

Forest plot of CGRP mAb vs. placebo for the changes in baseline monthly migraine days. The estimated pooled WMD was − 1.44 (95% CI, − 1.68 to − 1.19) with high statistical significance (P < 0.00001). There was low heterogeneity among the studies (I2 = 6%). SD standard deviation, CI confidence interval, WMD weighted mean difference